Scalp application of the antioxidant piroctone olamine reduces hair shedding in an 8-week randomized, double-blind, placebo-controlled clinical study

被引:3
|
作者
Davis, Michael G. [1 ]
Piliang, Melissa P. [2 ,3 ]
Bergfeld, Wilma F. [2 ,3 ]
Caterino, Tamara L. [1 ]
Fisher, Brian K. [1 ]
Sacha, Jarek P. [1 ]
Carr, Greg J. [1 ]
Moulton, Laura T. [1 ]
Whittenbarger, Deborah J. [1 ]
Punyani, Supriya [4 ]
Schwartz, James R. [1 ]
机构
[1] Procter & Gamble Co, Mason, OH 45040 USA
[2] Cleveland Clin, Dept Dermatol, Cleveland, OH 44106 USA
[3] Cleveland Clin, Dept Pathol, Cleveland, OH 44106 USA
[4] Procter & Gamble Co, Singapore, Singapore
关键词
antioxidant; hair growth; hair loss; hair shedding; hair treatment; scalp; skin barrier; OXIDATIVE STRESS; SEBORRHEIC DERMATITIS; IRON; DANDRUFF;
D O I
10.1111/ics.12737
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Objective Increasing scalp hair fullness is a global unmet consumer need. An approach to decrease hair shedding by reducing scalp stratum corneum oxidation via a combination of antioxidant and barrier-enhancing technologies has been previously demonstrated. The purpose of this study was to test the effectiveness of the individual antioxidant piroctone olamine in two different product forms (shampoo or leave-on product) for activity to improve hair retention. Methods Female subjects with self-perceived hair thinning participated in an 8-week, double-blind, placebo-controlled, randomized clinical study to evaluate either a piroctone olamine (PO) containing shampoo or a PO containing leave on treatment, each relative to their corresponding placebo formulation Too many periods. Results for phototrichograms, TEWL, and biomarker analysis of scalp condition for the shampoo treatments are discussed. Phototrichogram results are shared for the assessment of the leave on treatment. Results Statistically significant increases in hair amount were observed by phototrichogram after use of both PO-containing products versus placebo formulations. The PO shampoo treatment also significantly decreased oxidative stress on the hair and scalp, and improved scalp condition as assessed by TEWL and scalp biomarker values. Conclusion These results illustrate the effectiveness of a cosmetic antioxidant to improve scalp condition thereby improving hair retention. The observed improvements in scalp condition are consistent with previous reports with other antioxidant technologies and suggest that the hair retention effect was achieved by preventing oxidative damage to the scalp.
引用
收藏
页码:S26 / S33
页数:8
相关论文
共 50 条
  • [1] Scalp application of antioxidants improves scalp condition and reduces hair shedding in a 24-week randomized, double-blind, placebo-controlled clinical trial
    Davis, Michael G.
    Piliang, Melissa P.
    Bergfeld, Wilma F.
    Caterino, Tamara L.
    Fisher, Brian K.
    Sacha, Jarek P.
    Carr, Gregory J.
    Moulton, Laura T.
    Whittenbarger, Deborah J.
    Schwartz, James R.
    [J]. INTERNATIONAL JOURNAL OF COSMETIC SCIENCE, 2021, 43 : S14 - S25
  • [2] Intranasal Oxytocin as an Adjunct to Risperidone in Patients with Schizophrenia An 8-Week, Randomized, Double-Blind, Placebo-Controlled Study
    Modabbernia, Amirhossein
    Rezaei, Farzin
    Salehi, Bahman
    Jafarinia, Morteza
    Ashrafi, Mandana
    Tabrizi, Mina
    Hosseini, Seyed M. R.
    Tajdini, Masih
    Ghaleiha, Ali
    Akhondzadeh, Shahin
    [J]. CNS DRUGS, 2013, 27 (01) : 57 - 65
  • [3] Safety and Efficacy of Esreboxetine in Patients With Fibromyalgia: An 8-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
    Arnold, Lesley M.
    Chatamra, Krai
    Hirsch, Ian
    Stoker, Malcolm
    [J]. CLINICAL THERAPEUTICS, 2010, 32 (09) : 1618 - 1632
  • [4] Intranasal Oxytocin as an Adjunct to Risperidone in Patients with SchizophreniaAn 8-Week, Randomized, Double-Blind, Placebo-Controlled Study
    Amirhossein Modabbernia
    Farzin Rezaei
    Bahman Salehi
    Morteza Jafarinia
    Mandana Ashrafi
    Mina Tabrizi
    Seyed M. R. Hosseini
    Masih Tajdini
    Ali Ghaleiha
    Shahin Akhondzadeh
    [J]. CNS Drugs, 2013, 27 : 57 - 65
  • [5] A double-blind, placebo-controlled study of the clinical efficacy of ciclopirox olamine (1.5%) shampoo for the control of scalp psoriasis
    Shuttleworth, D
    Calloway, DB
    Boorman, GC
    Donald, AE
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 1998, 9 (03) : 163 - 167
  • [6] A Randomized, Double-Blind, Placebo-Controlled, 8-Week Study of Vilazodone, a Serotonergic Agent for the Treatment of Major Depressive Disorder
    Khan, Arif
    Cutler, Andrew J.
    Kajdasz, Daniel K.
    Gallipoli, Susan
    Athanasiou, Maria
    Robinson, Donald S.
    Whalen, Heidi
    Reed, Carol R.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (04) : 441 - +
  • [7] An 8-week, randomized, double-blind, placebo-controlled, multicenter study of esreboxetine administered once daily in patients with fibromyalgia
    Arnold, Lesley
    Chatamra, Krai
    Hirsch, Ian
    Stoker, Malcolm
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S434 - S434
  • [8] A randomized, double-blind, placebo-controlled clinical trial of 8-week intranasal oxytocin administration in adults with obesity: Rationale, study design, and methods
    Wronski, Marie-Louis
    Plessow, Franziska
    Kerem, Liya
    Asanza, Elisa
    O'Donoghue, Michelle L.
    Stanford, Fatima C.
    Bredella, Miriam A.
    Torriani, Martin
    Soukas, Alexander A.
    Kheterpal, Arvin
    Eddy, Kamryn T.
    Holmes, Tara M.
    Deckersbach, Thilo
    Vangel, Mark
    Holsen, Laura M.
    Lawson, Elizabeth A.
    [J]. CONTEMPORARY CLINICAL TRIALS, 2022, 122
  • [9] An 8-Week Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Cariprazine in Patients With Bipolar I Depression
    Durgam, Suresh
    Earley, Willie
    Lipschitz, Alan
    Guo, Hua
    Laszlovszky, Istvan
    Nemeth, Gyorgy
    Vieta, Eduard
    Calabrese, Joseph R.
    Yatham, Lakshmi N.
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2016, 173 (03): : 271 - 281
  • [10] Cariprazine Monotherapy for the Treatment of Bipolar I Depression: Results: of an 8-Week, Double-blind, Placebo-controlled Study
    Calabrese, Joseph R.
    Durgam, Suresh
    Lipschitz, Alan
    Guo, Hua
    Earley, Willie
    Laszlovszky, Istvan
    Nemeth, Gyoergy
    [J]. NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S335 - S336